Nab-paclitaxel + Carboplatin trials for Breast cancer

All Nab-paclitaxel + Carboplatin trials · All Breast cancer trials

Phase breakdown

Recruiting trials studying Nab-paclitaxel + Carboplatin for Breast cancer

• Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer
  NCT04159142 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer
  NCT04138719 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
• Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT
  NCT04137653 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: Female · 1 location

Common questions

How many trials study Nab-paclitaxel + Carboplatin for Breast cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.